Apyx Medical Ownership

APYX Stock  USD 2.26  0.02  0.88%   
Apyx Medical holds a total of 37.79 Million outstanding shares. 30% of Apyx Medical outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
 
Shares in Circulation  
First Issued
2000-03-31
Previous Quarter
38.2 M
Current Value
35.5 M
Avarage Shares Outstanding
23.1 M
Quarterly Volatility
8.1 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Some institutional investors establish a significant position in stocks such as Apyx Medical in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Apyx Medical, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Apyx Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
For more information on how to buy Apyx Stock please use our How to Invest in Apyx Medical guide.

Apyx Stock Ownership Analysis

About 15.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.54. Apyx Medical had not issued any dividends in recent years. Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida. Apyx Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 272 people. For more info on Apyx Medical please contact Charles II at 727 384 2323 or go to https://apyxmedical.com.
Besides selling stocks to institutional investors, Apyx Medical also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Apyx Medical's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Apyx Medical's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.

Apyx Medical Quarterly Liabilities And Stockholders Equity

60.16 Million

Apyx Medical Insider Trades History

About 15.0% of Apyx Medical are currently held by insiders. Unlike Apyx Medical's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Apyx Medical's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Apyx Medical's insider trades
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid

Apyx Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Apyx Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Apyx Medical backward and forwards among themselves. Apyx Medical's institutional investor refers to the entity that pools money to purchase Apyx Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Perkins Capital Management Inc2025-03-31
205.5 K
Renaissance Technologies Corp2025-03-31
202 K
Kingsview Wealth Management, Llc2025-03-31
175.1 K
Perceptive Advisors Llc2025-03-31
150 K
Northern Trust Corp2025-03-31
119.3 K
State Street Corp2025-03-31
109.3 K
Caption Management, Llc2025-03-31
107.9 K
Rathbone Brothers Plc2025-03-31
101.3 K
Dimensional Fund Advisors, Inc.2025-03-31
99.3 K
Archon Capital Management Llc2025-03-31
3.3 M
Nantahala Capital Management, Llc2025-03-31
3.3 M
Note, although Apyx Medical's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Apyx Medical Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Apyx Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Apyx Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Apyx Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Hill Matthew C over a month ago
Acquisition by Hill Matthew C of 6000 shares of Apyx Medical at 1.13 subject to Rule 16b-3
 
Goodwin Charles D. Ii over a month ago
Acquisition by Goodwin Charles D. Ii of 243000 shares of Apyx Medical at 2.42 subject to Rule 16b-3
 
Andres John C. over a month ago
Disposition of 17000 shares by Andres John C. of Apyx Medical at 4.25 subject to Rule 16b-3
 
Hill Matthew C over two months ago
Acquisition by Hill Matthew C of 100000 shares of Apyx Medical at 1.48 subject to Rule 16b-3
 
Levine Wendy Lauren over two months ago
Acquisition by Levine Wendy Lauren of 64000 shares of Apyx Medical at 1.48 subject to Rule 16b-3
 
Geraghty Michael over three months ago
Acquisition by Geraghty Michael of 6000 shares of Apyx Medical at 2.79 subject to Rule 16b-3
 
Geraghty Michael over three months ago
Disposition of 10000 shares by Geraghty Michael of Apyx Medical at 2.79 subject to Rule 16b-3
 
Moshe Citronowicz over six months ago
Acquisition by Moshe Citronowicz of 36000 shares of Apyx Medical at 1.42 subject to Rule 16b-3
 
Swandal Craig A. over six months ago
Acquisition by Swandal Craig A. of 10000 shares of Apyx Medical at 5.3 subject to Rule 16b-3
 
Waldman Lawrence over six months ago
Disposition of 24000 shares by Waldman Lawrence of Apyx Medical at 2.54 subject to Rule 16b-3
 
Todd Hornsby over six months ago
Acquisition by Todd Hornsby of 15000 shares of Apyx Medical at 1.77 subject to Rule 16b-3
 
Vizirgianakis Stavros G. over six months ago
Disposition of tradable shares by Vizirgianakis Stavros G. of Apyx Medical subject to Rule 16b-3

Apyx Medical Outstanding Bonds

Apyx Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Apyx Medical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Apyx bonds can be classified according to their maturity, which is the date when Apyx Medical has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Apyx Stock Analysis

When running Apyx Medical's price analysis, check to measure Apyx Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apyx Medical is operating at the current time. Most of Apyx Medical's value examination focuses on studying past and present price action to predict the probability of Apyx Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apyx Medical's price. Additionally, you may evaluate how the addition of Apyx Medical to your portfolios can decrease your overall portfolio volatility.